IGC Pharma, Inc. (IGC) Q4 2026 Earnings Report, Transcript and Summary
IGC Pharma, Inc. (IGC)
Q4 2026 Earnings Call· Fri, Jun 26, 2026
$0.25
-0.81%
IGC Pharma, Inc. Q4 2026 Earnings Call Key Takeaways
AI summary not available yet
Be the first to generate an AI summary of this earnings call. Takes about 20 seconds, and the result is saved and available to everyone afterwards.
IGC Pharma, Inc. Q4 2026 Revenue and EPS Results
REVENUE
BEAT +37.8%$317k
vs $230k est
−10%est+10%
YoY —·QoQ +5.7%
EPS
BEAT +0.0%-$0.02
vs -$0.02 est
−40%est+40%
YoY —·QoQ -100.0%
Stock Price Reaction to IGC Pharma, Inc. Q4 2026 Earnings
Same-Day
+3.04%
1 Week
+6.84%
1 Month
-8.75%
vs S&P
-8.81%
IGC Pharma, Inc. Q4 2026 Earnings Call Transcript
Transcript not yet available
Earnings call transcripts typically publish within 24 hours of the call. Check back soon — we publish transcripts the moment they're available from our data provider.
Call date: Friday, June 26, 2026